Microscan Microstrep Plus Panel New Antimicrobial-Clindamycin

FDA 510(k) K021184 · Dade Microscan, Inc.

Substantially Equivalent

510(k) numberK021184

Submission

Device name
Microscan Microstrep Plus Panel New Antimicrobial-Clindamycin
Applicant
Dade Microscan, Inc.
West Sacramento, CA, US
Received
April 15, 2002
Decision date
June 20, 2002
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LTT – Panels, Test, Susceptibility, Antimicrobial
Device class
Class II (moderate risk)
Regulation
21 CFR 866.1640
Specialty
Microbiology

Other 510(k)s with product code LTT

510(k)DeviceApplicantDecision
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional Beckman Coulter, Inc.08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional Beckman Coulter, Inc.08/15/2025SE
K250084MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)LTT · Traditional Beckman Coulter, Inc.07/18/2025SE
K202343MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL )LTT · Traditional Beckman Coulter, Inc.11/16/2020SE
K201423MicroScan Dried Gram-Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32 µg/mL)LTT · Special Beckman Coulter, Inc.06/29/2020SE
K193536MicroScan Dried Gram Negative MIC/Combo Panels with Ciprofloxacin (Cp) (0.004 - 8µg/mL)LTT · Traditional Beckman Coulter, Inc.03/18/2020SE
K193358MicroScan Dried Gram-Negative MIC/Combo Panels with Levofloxacin (Lvx) (0.008-16ug/mL)LTT · Traditional Beckman Coulter, Inc.03/03/2020SE
K183127MicroScan Dried Gram Negative MIC/Combo Panels with Meropenem/Vaborbactam…LTT · Traditional Beckman Coulter, Inc.02/12/2019SE
K172337MicroScan Dried Gram Negative MIC/Combo Panels with Ceftazidime/Avibactam (0.25/4 - 64/4…LTT · Traditional Beckman Coulter, Inc.12/15/2017SE
K172912MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 – 8 µg/mL)LTT · Traditional Beckman Coulter, Inc.12/07/2017SE

More from Beckman Coulter, Inc.

510(k)DeviceDecision
K043589Microscan Dried Gram-Positive Mic/Combo Panels - ErtapenemJWY · Traditional 02/14/2005SE
K023202Microscan Synergies PlusJWY · Special 10/23/2002SE
K021181Microscan Microstrep Plus Panel New Anticrobial-ClarithromycinJWY · Traditional 06/17/2002SE
K021018Microscan Microstrep Plus Panel - ChloramphenicolJWY · Traditional 06/11/2002SE
K021188Microscan Microstrep Plus Panel New Antimicrobial-CefepimeJWY · Traditional 06/06/2002SE
K021169Microstrep Plus Panel, AzithromycinJWY · Traditional 06/06/2002SE
K021111Microscan Microstrep Plus Panel New Antimicrobial - CefotaximeLTT · Traditional 06/06/2002SE
K021110Microscan Microstrep Plus Panel New Antimicrobial- CeftriaxoneJWY · Traditional 06/06/2002SE
K021078Microscan Microstrep Plus Panel New Antimicrobial-ErythromycinLTT · Traditional 06/06/2002SE
K020938Microscan Microstrep Plus Panel-MeropenemJWY · Traditional 06/03/2002SE

Questions and answers

When was Microscan Microstrep Plus Panel New Antimicrobial-Clindamycin cleared by the FDA?

Microscan Microstrep Plus Panel New Antimicrobial-Clindamycin (K021184) received a 510(k) decision of Substantially Equivalent on June 20, 2002, 66 days after the submission was received.

What is the product code of K021184?

The FDA product code is LTT – Panels, Test, Susceptibility, Antimicrobial, a Class II (moderate risk) device regulated under 21 CFR 866.1640.